Agnes Fonseca Ribeiro Filardi, VÂnia Eloisa De AraÚjo, Yone De Almeida Nascimento, Djenane Ramalho De Oliveira


The use of psychotropic drugs to treat problems of everyday life is a growing phenomenon in many countries. A systematic review was conducted as a method of synthesis of results of the qualitative primary studies developed to explore the perspective of health professionals and patients regarding the use of psychotropic drugs to overcome personal problems. This systematic review was conducted in the databases Medline (PubMed), Central (Cochrane), Psycoinfo and Lilacs, including gray literature and manual search (june/2015). We identified 581 publications that were evaluated in stages and 26 met the inclusion criteria with a total of 876 participants including health professionals and patients. The doctors showed empathy by prescribing. The health professionals-prescribers and non-prescribers-were concerned about the dependence of patients on the psychotropic and the pressure to prescribe. Patients felt unable to solve their problems and seek medications as a solution. The psychotropics were considered a useful resource to overcome the social problems, existing denial of its side effects as well as the lack of openness and access to other support mechanisms.


Psychotropic, Health professionals, Prescribers, Non-prescribers, Patients, Qualitative research, Systematic review

| PDF | HTML |


Illich I. A expropriacao da saude: nemesis da medicina. 4. ed. Sao Paulo (SP): Nova Fronteira; 1975.

Lefevre F. A funcao simbolica dos medicamentos. Sao Paulo (SP), Brasil. Rev Saude Publica 1983;17:500-3.

Healy D. Let them eat Prozac. New York and London: New York University Press; 2004.

Tesser CD. Medicalizacao social (I): o excessivo sucesso do epistemicidio moderno na saude. Interface-Comunic Saude Educ 2006;9:61-76.

Silva VP, Nadja CLB, Oliveira VC, Guimarães EAA. Perfil epidemiólogico dos usuários de benzodiazepínicos na atenção primária à saúde. R Enferm Cent O Min 2015;5:1393-400.

Nelson J, Chouinard G. Guidelines for the clinical use of benzodiazepines: pharmacokinetics, dependency, rebound and withdrawal. Can J Clin Pharmacol 1999;6:69-83.

Firmino KF, Abreu MHNG, Perini E, Magalhães SMS. Fatores associados ao uso de benzodiazepínicos no serviço municipal de saúde da cidade de coronel fabriciano, minas gerais, Brasil. Cad Saude Publica 2011;7:1223-32.

Anthierens S, Habraken H, Petrovic M, Deveugele M, Maeseneer JD, Christiaens T. First benzodiazepine prescriptions; Qualitative study of patients’perspectives. Can Fam Physician 2007;53:1200-5.

Morrison J, Anderson MJ, Sutton M, Munoz-Arroyo R, McDonald S, Maxwell M, et al. Factors influencing variation in prescribing of antidepressants by general practices in Scotland. Br J Gen Pract 2009;59:25-31.

Olfson M, Marcus SC. National patterns in antidepressant medication treatment. Arch Gen Psychiatry 2009;66:848-56.

Macdonald S, Morrison J, Maxwell M, Munoz-Arroyo R, Power A, Smith M, et al., ‘A coal face option’; gps’ perspectives on the rise in antidepressant prescribing. Br J Gen Pract 2009;59:299-307.

Rodrigues MAP, Facchini LA, Lima MS. Modificações nos padrões de consumo de psicofármacos em localidade do sul do Brasil. Rev Saude Publica 2006;40:107-14.

Netto MUQ, Freitas O, Pereira LRL. Antidepressivos e benzodiazepínicos: estudo sobre o uso racional entre usuários do SUS em Ribeirão Preto-SP. Rev Cienc Farm Basica Apl 2012;33:77-81.

Duarte PCAV, Stempliuk VAS, Barroso LP. editors. Relatório brasileiro sobre drogas; sumário executivo. Brasília: SENAD; 2009.

Queiroz Netto, UM, Freitas O, Pereira LRL. Antidepressivos e Benzodiazepínicos: estudo sobre o uso racional entre usuários do SUS em Ribeirão Preto-SP. Rev Cienc Farm Basica Apl 2012;33:77-81.

Stephenson CP, Karanges E, McGregor IS. Trends in the utilisation of psychotropic medications in Australia from 2000 to 2011. Aust N Z J Psychiatry 2013;47:74-87.

Lawrenson RA, Tyrer F, Newson RB, Farmer RDT. The treatment of depression in UK general practice: selective serotonin reuptake inhibitors and tricyclic antidepressants compared. J Affect Disord 2000;59:149–57.

Munoz-Arroyo R, Sutton M, Morrison J. Exploring potential explanations for the increase in antidepressant prescribing in Scotland using secondary analyses of routine data. Br J Gen Pract 2006;56:423–8.

Souza CAC. Uso racional de antidepressivos. Souza, Carlos Alberto Crespo (Org.) In: O uso de antidepressives na clínica médica. Porto Alegre: Sulina; 2011. p. 55-101.

Western Australian Psychotropic Drugs committee Anxiety Disorders Drug Treatment Guidelines; 2008. Available from: [Last accessed on 10 Jan 2017]

World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders. Clinical descriptions and diagnostic guidelines. World Health Organization; 2010. Available from: [Last accessed on 10 Jan 2017]

Katzman MA, Bleau P, Blier P, Chokka P, Kjernisted K, Van Ameringen M. Canadian clinical practice guidelines for the management of anxiety, post-traumatic stress and obsessive-compulsive disorders. BMC Psychiatry 2014;14(Suppl 1):S1.

Griffin CE, Kaye AM, Bueno FR, Kaye AD. Benzodiazepine pharmacology and central nervous system–mediated effects. Ochsner J 2013;13:214–23.

Wennberga AM, Canhama SL, Smith MT, Spira AP. Optimizing sleep in older adults: Treating insomnia. Maturitas 2013:76:247–52.

D’Incau P, Barbui C, Tubini J, Conforti A. Stressful life events and social health factors in women using anxiolytics and antidepressants: an italian observational study in community pharmacies. Gend Med 2011;8:80-92.

Mercier A, Auger-Aubin I, Lebeau JP, Schuers M, Boulet P, Hermil JL, et al. Evidence of prescription of antidepressants for non-psychiatric conditions in primary care: an analysis of guidelines and systematic reviews. BMC Family Practice 2013;14:55.

Sirdifield C, Anthierens S, Creupelandt H, Chipchase SY, Thierry C, Siriwardena AN. General practitioners’ experiences and perceptions of benzodiazepine prescribing: systematic review and meta-synthesis. BMC Family Practice 2013;14:2-13.

Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. Annals Internal Med 2009;151:W-65.

Dickinson R, Knapp P, House AO, Dimri V, Zermansky A, Petty D, et al. Long-term prescribing of antidepressants in the older population: a qualitative study. Br J Gen Pract 2010;60:144-55.

Gabe J, Lipshitz-Phillips S. Tranquillisers as social control? Soc Rev 1984;32:24–546.

Pérodeau G, Paradis I, Grenier S, O’Connor K, Grenon E. Chronic psychotropic drug use among frail elderly women receiving home care services. J Women Aging 2011;23:321–41.

Hedenrud TM, Svensson SA, Wallerstedt SM. “Psychiatry is not a science like others”-a focus group study on psychotropic prescribing in primary care. BMC Fam Pract 2013;14:115.

Orlandi P. Noto AR Uso Indevido de Benzodiazepínicos: Um Estudo com Informantes-Chave no Município de São Paulo. Rev Latino-am Enfermagem 2005;13:896-902.

Hassan L, Edge D, Senior J, Shaw J. Staff and patient perspectives on the purpose of psychotropic prescribing in prisons: care or control? Gen Hosp Psychiatry 2013;35:433–8.

Hyde J, Calnan M, Prior L, Lewis G, Kessler D, Sharp D. A qualitative study exploring how GPs decide to prescribe antidepressants. Br J Gen Pract 2005;55:755-62.

Tentler A, Silberman J, Paterniti DA, Kravitz RL, Epstein RM. Factors affecting physicians’ responses to patients’ requests for antidepressants: focus group study. J Gen Intern Med 2008;23:51–7.

Cook JM, Marshall R, Masci C, Coyne JC. Physicians’ perspectives on prescribing benzodiazepines for older adults: a qualitative study. J Gen Intern Med 2007;22:303-7.

Dybwad TB, Kjolsrod L, Eskerud J, Laerum E. Why are some doctors high-prescribers of benzodiazepines and minor opiates? A qualitative study of GPs in Norway. Fam Pract 1997;14:361-8.

Anthierens S, Habraken H, Petrovic M, Christiaens T. The lesser evil? Initiating a benzodiazepine prescription in general practice. Scandinavian J Primary Health Care 2007;25:214-9.

Rogers A, Pilgrim D, Brennan S, Sulaiman I, Watson G, Chew-Graham C. Prescribing benzodiazepines in general practice: a new view of an old problem. Health (London) 2007;11:181-98.

Knudsen P, Hansen EH, Traulsen JM, Eskildsen K. Changes in self-concept while using SSRI antidepressants. Qual Health Res 2002;12:932-44.

Stevenson F, Knudsen P. Discourses of agency and the search for the authentic self: the case of mood-modifying medicines. Soc Sci Med 2008;66:170–81.

Verbeek-Heida PM, Mathot EF. Better safe than sorry-why patients prefer to stop using selective serotonin reuptake inhibitor (SSRI) antidepressants but are afraid to do so: results of a qualitative study. Chronic Illness 2006;2:133–42.

Leydon GM, Rodgers L, Kendrick T. A qualitative study of patient views on discontinuing long-term selective serotonin reuptake inhibitors. Family Practice 2007;24:570–5.

Cook JM, Biyanova T, Masci C, Coyne JC. Older patient perspectives on long-term anxiolytic benzodiazepine use and discontinuation: a qualitative study. J Gen Intern Med 2007;22:1094-100.

Mendonça RT, Carvalho ACD. O papel de mulheres idosas consumidoras de calmantes alopáticos na popularização do uso destes medicamentos. Rev Latino-Am Enfermagem 2005;13:1207-12.

Barter G, Cormack M. The long-term use of benzodiazepines: patients' views, accounts and experiences. Family Practice 1996;13:491-7.

Cooperstock R, Lennard HL. Some social meanings of tranquilizer use. Soc Health Illn 1979;1:331-47.

North D, Davis P, Powell A. Patient releases to benzodiazepine medication: a typology of adaptive repertoires developed by Icmg-tam user. Soc Health Illn 1995;17:632-65.

Dias JRF, Araújo CS, Martins ERC, Closi AC, Francisco MTR, Sampaio CEP. Fatores predisponentes ao uso próprio de psicotrópicos por profissionais de enfermagem. Rev Enferm 2011;19:445-51.

Outram S, Murphy B, Cockburn J. Prevalence of and factors associated with midlife women taking medicines for psychological distress. AeJAMH 2006;5:1-13.

Kartalova-O’Doherty Y, Doherty DT. Recovering from mental health problems: perceived positive and negative effects of medication on reconnecting with life. Int J Soc Psychiatry 2010;57:610–8.

Mazza D, Dennerstein L, Ryan V. Psychotropic drug use by women: current prevalence and associations. Med J Aust 1995;163:87-9.

Mahtani-Chugani V, Sanz EJ. Users perception of risk and benefits of mood modifying drugs. Curr Clin Pharmacol 2011;6:1-7.

Forsan MA. O uso indiscriminado de benzodiazepínicos: uma análise crítica das práticas de prescrição, dispensação e uso prolongado. [Trabalho de conclusão de curso de especialização em Atenção Básica em Saúde da Família] Belo Horizonte: Universidade Federal de Minas Gerais; 2010.

Chaves CMS. Como viver sem meu prozac? uma análise antropológica dos discursos sobre o consumo de fluoxetina em um site de relacionamentos. [Trabalho de conclusão de curso para obtenção do título de Mestre em Saúde Coletiva] Programa de Pós-graduação em Saúde Coletiva–área de concentração em Ciências Humanas e Saúde Instituto de Medicina Social Rio de Janeiro; 2007.

Nielsen M. Selective serotonin reuptake inhibitors (SSRI)–sales, withdrawal reactions and how drug regulators reacted to this with benzodiazepines as comparator. 2012, 93 f. (PhD thesis from Faculty of Health Sciences) University of Copenhagen, Denmark; 2012.

Rogers CR, Kinget MEG. Psicoterapia e relações humanas: teoria e prática da terapia não diretiva. Vol. 1. 2 ed. Belo Horizonte; 1977. p. 288.

About this article




Pharmaceutical Care


Psychotropic, Health professionals, Prescribers, Non-prescribers, Patients, Qualitative research, Systematic review





Additional Links

Manuscript Submission


Journal of Critical Reviews
Vol 4, Issue 3, 2017 Page: 1-8

Online ISSN



176 Views | 16 Downloads

Authors & Affiliations

Agnes Fonseca Ribeiro Filardi
PhD’ student in Program of Medicines and Pharmaceutical Assistance, College of Pharmacy, Federal University of Minas Gerais.

VÂnia Eloisa De AraÚjo
Research in Pharmacoepidemiology, College of Pharmacy, Federal University of Minas Gerais.

Yone De Almeida Nascimento
PhD’ student in Program of Medicines and Pharmaceutical Assistance, College of Pharmacy, Federal University of Minas Gerais.

Djenane Ramalho De Oliveira
Professor and Director, Centro de Estudos em Atenção Farmacêutica (Center for Pharmaceutical Care Studies), Department of Social Pharmacy, College of Pharmacy, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil


  • There are currently no refbacks.